Introduction
Parkinson’s disease (PD) is an age related, progressive neurodegenerative disorder. It affects one in a thousand people over 60 years of age and is a substantial source of economic cost. Although both genetic and environmental factors are implicated in the development of PD, the cause of disease is still unclear. The clinical manifestation of PD motor symptoms includes bradykinesia, resting tremor, rigidity of muscles and joints, gait and posture imbalance. The occurrence of motor symptoms is mainly caused by the severe loss of dopaminergic neurons in the substance nigra of middle brain and subsequent depletion of dopamine in the striatum (Hornykiewicz, 2001; Obeso et al., 2008). The non-motor symptoms of PD are found in the vast majority of patients with PD, consisting of autonomic dysfunction, neuropsychiatric disturbance, sleep disorders, gastrointestinal symptoms and many others (Chaudhuri et al., 2006, 2011; Garcia-Ruiz et al., 2014). The non-motor symptoms of PD and related disorders usually respond poorly to dopaminergic treatment. This indicates, in addition to the loss of dopamine, the changes in other neurotransmitters, such as serotonin, norepinephrine and gammaaminobutyric acid (GABA) and glutamate, in the different brain regions and peripheral nervous systems, are involved in the pathogenesis of many non-motor symptoms (Ferrer, 2006). There is currently no cure for PD. The prevalence medication for motor symptoms, such as dopamine replacement therapy, in particular levodopa treatment, is only symptomatic relief with limited effect, but has many adverse effects, e.g. dyskinesia (Olanow, 2013; Salat & Tolosa, 2013; Connolly & Lang, 2014).
Acupuncture has been used to treat many conditions in China for more than 3000 years. Acupuncture is now one of the most popular complementary medicines, and is used for the treatment of a variety of disorders worldwide. In general, acupuncture needle inserted at the specific acupoint stimulates nerve receptors both directly or indirectly, through mechanical coupling via the connective tissues surrounding the needle, then through the local reflex and the central nervous system, induces endocrine, neuroendocrine, autonomic and systemic behavioural responses (Dong et al., 2002; Langevin et al., 2002) This suggests that acupuncture therapy beneficially affects a whole body even if it stimulates, through the fine needles, only limited sites on the body. Within past a few decades acupuncture has become increasingly popular with both public and medical professionals, and it has been reported to be a very safe and welltolerated therapy with only minor side effects (Posadzki et al., 2012; Rabinstein & Shulman, 2003; Shulman et al., 2002). Many patients with PD are reported using acupuncture as an alternative treatment at some points of their life. Indeed, it has been estimated that more than a quarter of PD patients in the United State (40%), Britain (38.7%), Sweden (34.5%), Singapore (61%), and Argentina (25.7%) have used at least one form of complementary medicine, while 7-49% of them have used acupuncture as an alternative therapy (Ferry et al., 2002; Pecci et al., 2010; Rajendran et al., 2001; Tan et al., 2006; Lökk et al., 2010) Many patients with PD experienced improvement of their conditions after acupuncture.
Literature Search
The following electronic databases were searched in December 2014 for publications between 2000 and 2014: (1) Pubmed; (2) Medline; (3) EMBASE; (4) CNKI and (5) CINAHL. The reference list of relevant studies and reviews were manually searched in order to identify more potential papers. The search term used in the studies were crossreferenced acupuncture and its proprietary names, and PD and with its derivations.
Summary of Clinical Trials – Table 1
Discussion
Present study reviewed the data of 519 patients with PD from 14 clinical studies. The results from some of the included studies showed the potential benefits of acupuncture for treating PD, especially non-motor symptoms seems to be more beneficial from acupuncture treatment. However, many methodological flaws presented in most studies limited the reliability of results. Therefore, the results included in this study should be interpreted with cautious.
Outcome measures for motor symptoms differed among the included studies. For example, 7 studies used the UPDRS, 2 studies used Webster scale and another 5 studies only described changes in individual motor symptom. Among 7 studies used UPDRS, 4 studies showed moderate to marked improvement in UPDRS III motor scores before and after acupuncture, between acupuncture plus medication and medication alone groups. One study showed negative outcome in UPDRS III motor scores (Eng et al., 2006) and 2 studied presented minor to moderate improvement in total UPDRS scores. Two studies used Webster scale presented marked improvement in motor symptoms. Five of 14 studies described changes in individual motor symptom following acupuncture treatment. For example, Lei et al., (2014) described the improvement in balance, gait and postural transition following acupuncture. It is difficult to draw a valid comparative conclusion based on inconsistent outcome measures. Suitable outcome measures such as UPDRS should be applied as a standard outcome measure and full data on outcome measures including mean and standard deviation should be presented.
Although many of included studies showed a moderate to marked improvement in motor function, one study (Eng et al., 2006) reported a worsening in UPDRS motor scores (24.0 versus 26.4, P=0.018). In this study PD patients were given acupuncture treatment for 7 to 10 min, once a week for 6 months (Eng et al., 2006). However, patients in majority of included studies were given acupuncture for 20 to 60 min, 2 to 3 times a week. This implied that duration and frequency of intervention might play an important role in the outcome of treatment.
Although many non-motor symptoms occur even before the appearance of motor symptoms, only 9 of 14 studies reported presence of the non-motor symptoms. This is not surprise as patients do not spontaneously complain their non-motor symptoms to doctors (Chaudhuri et al., 2006). Within 9 studies, depression was the most reported symptom, followed by sleep disorder, constipation, and bladder dysfunction. This is consistent with other studies showing depression is one of the most complained non-motor symptoms from patients with PD (Gallagher & Schrag, 2012; Reijnders et al., 2009). All studies reported that acupuncture significantly improved depression of PD patients. Beck’s Depression Inventory (BDI), PDQ-39 and PDQ8 were applied to rate the changes in depression within different studies. This led to difficult for comparison as each instrument covered different aspect of item and made the data less reliable. Similarly the outcome of sleep disorder was measured by PDSS and ISI scores between studies. Outcome measures for other NMS were barely mentioned by relevant studies. Indeed, there is a need to achieve an agreement on what are the accepted outcome measures for NMS in PD.
Future clinical acupuncture study should follow accepted standards of methodology such as CONSORT and STRICTA checklists. In particular studies should have sufficiently large sample sizes, should be based on data from appropriate pilot studies and to ensure reproducibility. Even if further clinical studies confirm acupuncture to be therapeutic valuable more evidence should be required on whether it has matched the effectiveness of conventional medicine or has significant advantage over conventional medicine. Further, some common practical settings should help improve the quality of future clinical studies. So we propose that 1). Comprehensive assessment of PD patients, not only about motor symptoms also non-motor symptoms, should be conducted. 2). Using the well-established and universally recognized measures for motor and non-motor symptoms assessment, such as UPDRS in which the scores of each part should be reported. 3). Acupuncture treatment should include obligatory acupoints and optional acupoints. The former should include proven motorrelated acupoints such as GB34 and ST36 for motor symptom treatment [66-67]. The selection of latter is dependent on the non-motor symptoms and other conditions. 4). Needle duration should be expected to maintain at least 20 min each time for acupuncture to produce a certain level of therapeutic effect. 5). A proper follow-up to evaluate the sustainable therapeutic effect of acupuncture. We hope that this will help reduce the discrepancy between the studies and improve the quality of treatment.
Conclusion
Acupuncture either manual or electroacupuncture stimulation at specific acupoints relieved some motor symptoms in patients with Parkinson’s and markedly improved many non-motor symptoms such as psychiatric disorders, sleep problems and gastrointestinal symptoms. When it was used as an adjunct for levodopa, acupuncture improved therapeutic efficacy and reduced dosage and the occurrence of side effects of levodopa. However, the results were constrained by small sample sizes, methodological flaws, and blinding methods of studies. Although the evidence for the effectiveness of acupuncture for treating Parkinson’s is inconclusive, therapeutic potential of acupuncture seems quite promising. More studies, either comparative effectiveness research or high quality placebo-controlled clinical studies are warranted.
References
- Chae Y, Lee H, Kim H, Kim CH, Chang DI, Kim KM, Park HJ. Parsing brain activity associated with acupuncture treatment in Parkinson’s diseases. Mov Disord 2009;24:1794-802.
- Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006;5:235e45.
- Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Parkinson’s disease: the nonmotor issues. Parkinsonism Relat Disord 2011;17:717-23.
- Chen YL, Feng WJ, Zhang XL. Parkinson’s disease combined with overactive bladder syndrome treated with acupuncture and medication. Zhongguo Zhen Jiu 2012;32:215- 8.
- Cho SY, Shim SR, Rhee HY, Park HJ, Jung WS, Moon SK, et al. Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson’s disease.
- Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA 2014;311:1670-83.
- Cristian A, Katz M, Cutrone E,Walker RH. Evaluation of acupuncture in the treatment of Parkinson’s disease: A double-blind pilot study. Mov Disord 2005;20:1185–1188.
- Dong Q, Dong X, Li H, Sun G, Ren J, Sun Q, et al. The influence of electroacupuncture on the activity of deep body receptors. Shanghai J Acupuncture 2002;21:38–40.
- Eng ML, Lyons KE, Greene MS, Pahwa R. Open-label trial regarding the use of acupuncture and yin tui na in Parkinson’s disease outpatients: A pilot study on efficacy, tolerability, and quality of life. J Altern Complem Med 2006;12:395–399.
- Ferrer I. Neuropathology and neurochemistry of non motor symptoms in Parkinson’s disease. Parkinsons Dis 2011;2011:708404.
- Ferry P, Johnson M, Wallis P. Use of complementary therapies and non-prescribed medication in patients with Parkinson’s disease. Postgrad Med J 2002;78:612-4.
- Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P. Non-motor symptoms of Parkinson’s disease A review from the past. J Neurol Sci 2014;338:30-3.
- Gallagher DA, Schrag A. Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Dis 2012;46:581-9.
- Hornykiewicz O, Chemical neuroanatomy of the basal ganglia – normal and in Parkinson’s disease. J Chem Neuroanat 2001;22:3–12.
- Jiang XM, Huang Y, Zhuo Y, Gao YP. Therapeutic effect of scalp electroacupuncture on Parkinson disease. Nan Fang Yi Ke Da Xue Xue Bao 2006;26:114-6.
- Langevin HM, Churchill DL, Wu J, Badger GJ, Yandow JA, Fox JR, et al. Evidence of connective tissue involvement in acupuncture. FASEB J 2002;16:872–874.
- Lei H, Toosizadeh N, Schwenk M, Sherman S, Karp S, Parvaneh S, et al. Objective Assessment of Electro-acupuncture Benefit for Improving Balance and Gait in Patients with Parkinson’s Disease. Neurology 2014;82Supplement10:P3.074.
- Liang X, Chen F. The effects of the Seven Acupoints of the Cranial Base on health related quality of life for patients with Parkinson’s disease: a randomized controlled trial. Int J Trad Chin Med 2014;36:613-616.
- Lökk J, Nilsson M. Frequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson’ s disease at a neurological outpatient clinic. Parkinsonism Relat Disord 2010;16:540-544.
- Obeso JA, Marin C, Rodriguez-Oroz C, Blesa J, Benitez-Temiño B, Mena-Segovia J, Rodríguez M, Olanow CW. The basal ganglia in Parkinson’s disease: current concepts and unexplained observations. Ann Neurol 2008;64 Suppl 2:S30-46.
- Olanow CW, Schapira AH. Therapeutic prospects for Parkinson disease. Ann Neurol 2013;74:337-47.
- Pecci C, Rivas MJ, Moretti CM, Raina G, Ramirez CZ, et al. Use of complementary and alternative therapies in outpatients with Parkinson’s disease in Argentina. Mov Disord 2010;25:2094–2098.
- Posadzki P, Alotaibi A, Ernst E. (2012). Prevalence of use of complementary and alternative medicine (CAM) by physicians in the UK: A systematic review of surveys. Clinical Medicine 2012;12:505–512.
- Rabinstein AA, Shulman LM. (2003). Acupuncture in clinical neurology. The Neurologist 2003;9:137–148.
- Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson’s disease. Neurology 2001;57:790 –794.
- Reijnders JS, Ehrt U, Lousberg R, Aarsland D, Leentjens AF. The association between motor subtypes and psychopathology in Parkinson’s disease. Parkinsonism Relat Disord 2009;15:379-82.
- Ren XM. Fifty cases of Parkinson’s disease treated by acupuncture combined with madopar. J Tradit Chin Med. 2008;28:255-7.
- Salat D, Tolosa E. Levodopa in the treatment of Parkinson’s disease: current status and new developments. J Parkinsons Dis 2013;3:255-69.
- Shulman LM, Wen X, Weiner WJ, Bateman D, Minagar A, Duncan R, Konefal J., Acupuncture therapy for the symptoms of Parkinson’s disease. Mov Disord 2002;17:799-802.
- Tan LC, Lau PN, Jamora RD, Chan ES. Use of complementary therapies in patients with Parkinson’s disease in Singapore. Mov Disord 2006;21:86–89.
- Xia Y, Wang HD, Ding Y, Kang B, Liu WG. Parkinson’s disease combined with depression treated with electroacupuncture and medication and its effect on serum BDNF. Zhongguo Zhen Jiu 2012;32:1071-4.
- Yang DH, Shi Y, Jia YM. Influence of acupuncture plus drug in the amelioration of symptoms and blood antioxidant system of patients with Parkinson’s disease. Chin J Clin Reha 2006;10:14-16.
- Yuan Y, Chen F, Yang JS. Forty-nine cases of Parkinson’s disease treated by acupuncture adjunctive therapy. Zhongguo Zhen Jiu 2014;34:53-4.
- Zou Y. Clinical Observation on Acupuncture Treatment of Parkinson’s Syndrome. J Acupuncture and Tuina Science 2006;4:211-212.
Grateful acknowledgements are due to Bai-Yun Zeng & Kaicun Zhao (this paper was based on their article in CNS Neuroscience & Therapeutics, 22(2016) 333–341. entitled “Effect of Acupuncture on the Motor and Nonmotor Symptoms in Parkinson’s Disease—A Review of Clinical Studies”) as well as to Bai-Yun Zeng for his work in preparing this briefing paper.